Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 113 | 126 | +13 |
| Shares | 51.6M | 56.1M | +4.49M (+8.7%) |
| Value | $717.1M | $635.2M | −$81.9M (−11.4%) |
New holders (30)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (17)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Cormorant Asset Management, LP | 2,456,800 | $34.5M |
| First Light Asset Management, LLC | 631,064 | $8.85M |
| Perceptive Advisors LLC | 539,831 | $7.57M |
| Kingdon Capital Management, L.L.C. | 300,000 | $4.21M |
| StemPoint Capital LP | 281,287 | $3.95M |
| EAM Investors, LLC | 228,139 | $3.20M |
| Renaissance Technologies LLC | 173,611 | $2.44M |
| J. Goldman & Co LP | 50,766 | $712.2K |
| Fred Alger Management, LLC | 39,584 | $555.4K |
| Group One Trading, L.P. | 35,989 | $504.9K |
| Engineers Gate Manager LP | 27,462 | $385.3K |
| SEI Investments Co | 25,913 | $363.6K |
| Jump Financial, LLC | 19,866 | $278.7K |
| SG Americas Securities, LLC | 15,874 | $223.0K |
| Y-Intercept (Hong Kong) Ltd | 11,319 | $158.8K |
| Walleye Trading LLC | 2,193 | $30.8K |
| Caption Management, LLC | 2,000 | $28.1K |